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Abstract
Purpose Mechanical thrombectomy (MT) is an effective treatment for patients suffering from acute ischemic stroke. However,
recanalization fails in about 16.5% of interventions. We report our experience with unsuccessful MT and analyze technical
reasons plus patient-related parameters for failure.
Methods Five hundred ninety-six patients with acute ischemic stroke in the anterior circulation and intention to performMTwith
an aspiration catheter and/or stent retriever were analyzed. Failure was defined as 0, 1, or 2a on the mTICI scale. Patients with
failing MTwere analyzed for interventional progress and compared to patients with successful intervention, whereby parameters
included demographics, medical history, stroke presentation, and treatment.
Results One hundred of the 596 (16.8%) interventions failed. In 20 cases, thrombus could not be accessed or passed with the
device. Peripheral arterial occlusive disease is common in those patients. In 80 patients, true stent retriever failure occurred. In this
group, coagulation disorders are associated with poor results, whereas atrial fibrillation is associated with success.
The administration of intravenous thrombolysis and intake of nitric oxide donors are associated with recanalization success.
Intervention duration was significantly longer in the failing group.
Conclusion In 20% of failingMT, thrombus cannot be reached/passed. Direct carotid puncture or surgical arterial access could be
considered in these cases.
In 80% of failing interventions, thrombus can be passed with the device, but the occluded vessel cannot be recanalized. Rescue
techniques can be an option. Development of new devices and techniques is necessary to improve recanalization rates.
Assessment of pre-existing illness could sensitize for occurring complications.
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Introduction
Background
Mechanical thrombectomy (MT) is a therapeutic option for patients
with acute ischemic stroke; it becamemore important in recent years
due to several randomized controlled trials provingbetter therapeutic
outcome compared to intravenous tissue-type plasminogen activator
for intravenous thrombolysis (IVT) alone [1–5].
Literature reports success rates of about 83%, whereas 17%
of the interventions are not successful [6]. We report our ex-
perience with unsuccessful endovascular treatment and ana-
lyze technical reasons for failure as well as patient-related
parameters, especially medical history.
In our retrospective single-center study, we investigated all
treatment protocols of failing interventions and screened those
patients for associated pre-existing illness and medication.
There are many possible reasons for failure, from unsuccessful
vascular access to distal embolization, which are described in
recent literature [7, 8].
Elevation of recanalization rates is an important step for
improved stroke therapy and better patient outcome [9, 10].
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Methods and study design
In a retrospective single-center study, 596 patients with acute
ischemic stroke of the anterior circulation (internal carotid artery,
middle cerebral artery) were analyzed; they underwent MTwith
an aspiration catheter and/or stent retriever systems at the
neurovascular center of a German university hospital from
January 2014 to October 2018. At our center, MT is delivered
24/7 by 5 experienced neurointerventionalists. The study includ-
ed all patients with intention to perform interventional thrombol-
ysis in order to analyze any occurring circumstances leading to
unsuccessful recanalization.
In our study, failure was defined as 0, 1, or 2a on the mTICI
scale. The mTICI scale is a well investigated angiographic score
for measuring recanalization success [11]. Figure 1 provides an
overview of the selection process.
First, treatment protocols of unsuccessful MTs were inves-
tigated to find out the specific reasons of failure. Next, they
were analyzed for interventional progress in order to identify
the exact step when MT had failed.
Patients were analyzed for demographics, medical history
including long-term medication, localization of the occlusion,
severity of symptoms measured by the NIHSS [12], initial
blood laboratory, and acute therapy. In addition, elapsed time
from symptom onset to IVT and to interventional treatment
were recorded, as well as intervention duration.
Additionally, patients with unsuccessful recanalization are
divided into two subgroups, as indicated in Fig. 1.
Group A: Patients with technical-mechanical reasons for
failure (occlusion site cannot be passed with device).
Group B: Patients with other reasons for failure (occlu-
sion site can be passed but vessel cannot be completely
recanalized).
The failing group in total and the two subgroups A and B
were compared to a randomly selected group of 100 patients who
underwent successful MT (mTICI 2b, 2c, and 3) in the same
period at our center.
Data was recorded from treatment protocols, the angio-
graphic system, and medical reports at discharge. Clinical da-
ta, especially examination results at discharge or later, was not
collected at any time, since our study focused on angiographic
parameters.
Statistics
Absolute and relative frequencies are given for categorical
data, median and IQR, or mean and SD for metric variables,
as indicated. Comparisons of the group of successful interven-
tions with the group of failing interventions and subgroups A
and B were made using the Wilcoxon Mann-Whitney U test
for quantitative variables and with the Fisher’s exact test and
X2 test for qualitative variables, as appropriate. Significant
lever was set at 5%, with a p value ≤ 0.05 considered as
significant.
Statistical analysis was performed with SPSS, Version 25.0
(IBM Corporation, Armonk, New York, USA).
MT for acute ischemic stroke in anterior circulaon
n=596










other reasons for failure
(occlusion site can be passed 
but vessel cannot be 
completely recanalized)
n=80 (13,4%)





Fig. 1 Selection process and
subgroups’ definition
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Intervention procedure
MTwas performed immediately after CTand CTangiography
imaging under the following conditions: (1) acute ischemic
stroke with NIHSS > 3 or severe isolated neurological deficit
(aphasia, hemianopsia, isolated paresis of one limb), (2) large
vessel occlusion with corresponding neurological deficits, (3)
exclusion of hemorrhage, and (4) absence of any other indi-
vidual contraindications for thrombectomy.
All the interventions were performed under general anesthesia
and endotracheal intubation on a biplane angiography unit
(Siemens Axiom Artis, Siemens Healthcare, Erlangen,
Germany). The institution standard for occlusion of the anterior
circulation consists of femoral approach with a 6F sheath (Cook
Group Inc., Bloomington, Indiana, USA), which is placed as distal
as possible in the internal carotid artery. Radial vessel access is
very rare (1 of 100 in the failing group), and direct carotid puncture
is currently not performed at our center. After microwire-assisted
placement of the microcatheter, the microwire was exchanged for
a thrombectomy device, and a stent retriever was deployed in the
occluded vessel distal of the target lesion. Stent-retriever
thrombectomy was executed with manual aspiration. If the inter-
vention failed, another run was performed and/or material was
changed. The mean number of maneuvers in total was 2.9 ± 2.0
(mean ± SD), maximum 9.
In some cases, especially proximal occlusions of large vessels,
aspiration-first thrombectomywas carried out,while in other cases,
a microcatheter was not used due to access difficulties. The choice
ofmethod andmaterials wasmade by the neurointerventionalist as
well as the decision to terminate the procedure and to perform a
rescue technique as permanent stenting or intraarterial tissue plas-
minogen activator. At the end of the intervention, post-interven-
tional, the mTICI scale score was recorded.
Results
Between January 2014 and October 2018, 100 of the 596
(16.8%) interventions failed according to our definition: 49
patients had a post-interventional mTICI scale score of 0, 18
had an mTICI scale score of 1, and 33 had an mTICI scale
score of 2a. Table 1 gives an overview of failing interventions
during the years 2014 until 2018.
Demographic data
As shown in Table 2, there was no significant difference in age or
sex. Themedian agewas 73.4 ± 12.8 years in the successful group
and 71.1 ± 12.9 in the failing group. In subgroup B, patients seem
to be slightly younger (70.1 ± 13.3 years), without the difference
being significant. A small female predominance (n= 60; 60.0%)
can be observed in the successful group, while all the other groups
are almost equal in sex distribution (45.0–55.0%).
Interventional progress and material
Intervention was divided into 6 steps, as shown in Fig. 2.
In 20 of the 100 patients, it was not possible to reach and/or
pass the occlusive lesion (steps 1–3 in Fig. 2, technical-
mechanical reasons for failure). Most of them had elongation
(9/20, 45.0%) or stenosis (6/20; 30.0%), which could not be
passed with the endovascular device. In 2 cases (10.0%), fem-
oral puncture was not possible, and in 1 case (5.0%), a carotid
dissection was the reason for stroke symptoms. Thrombus
passage with a microcatheter or microwire was not possible
in 2 cases (10.0%). These 20 patients form group A, following
the subgroups’ definition above.
In 80 of the 100 patients, the occluded site could be reached
and/or passed, but the vessel could not be recanalized successfully
(steps 4–6 in Fig. 2, true stent retriever failure). Those 80 patients
form group B for the subgroup analysis. In most cases, peripheral
ramifications remained occluded after the intervention (40/80,
50.0%) or no clot material could be removed at all (25/80,
31.3%). Ten patients suffered from a re-occlusion, 6 (7.5%) at
the same site and 4 (5.0%) more proximal at a stent in the carotid
artery that was placed due to a tandem lesion. Subarachnoid hem-
orrhage (3/80, 3.8%) and iatrogenic dissection (1/80, 1.3%) lead-
ing to premature termination are rare. In 1 case (1.3%), interven-
tion was terminated for a high-risk profile (distal occlusion and
difficult vascular anatomy with high risk of vessel perforation).
During the study period from January 2014 to October 2018,
several types of stent retrievers and catheter systems were used in
the group of failing interventions: 104 stent retrievers, including 60
Solitaires (Covidien, Mansfield, Massachusetts, USA), 15 ERICs
(MicroVention, Tustin, California, USA), 16 embo-trap (Neuravi,
Galway, Ireland), 12 pRESET (Phenox, Bochum, Germany), and
1 TREVO (Stryker, Kalamazoo, Michigan, USA). Furthermore,
92 intermediate catheters were used: 57 Sofia Intermediate
Catheters (MicroVention, Tustin, CA, USA), 32 ACE or MAX
Reperfusion Catheters (Penumbra, Alameda, CA, USA), 1
Neurobridge Intermediate Catheter (Acandis, Pforzheim,
Germany), and 1 Envoy Guiding Catheter (DePuy Synthes
Codman Neuro, Raynham, MA, USA).
Evaluation of the 100 failing interventions produces the
following results: In 21 cases, nomaneuver at all was possible,
Table 1 Failing interventions from 2014 until 2018 by years
Number of
interventions
mTICI 0 mTICI 1 mTICI 2a % failing
2014 84 7 4 3 16.7%
2015 102 8 6 12 25.4%
2016 135 13 2 9 17.8%
2017 141 10 3 5 12.8%
01–10/2018 134 11 3 4 13.4%
2014–2018 596 49 18 33 16.8%
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for example, due to access problems. In 7 , a stent retriever-
alone maneuver and in 6 cases an aspiration-alone maneuver
was performed, while in the 66 remaining cases, a combina-
tion of aspiration and stent retriever withdrawal was conduct-
ed. In 9 cases, an aspiration catheter was changed during the
intervention; in 29 cases, a change of stent retriever was con-
ducted, and in one case, a stent retriever was changed twice.
In 19 patients, balloon angioplasty was performed during
the intervention; in 14, a stent was implanted.
Comparisons of medical history include long-term
medication, localization of the occlusion, severity
of symptoms, initial blood laboratory, and acute
therapy
All the characteristics of failing and successful intervention
groups are given in Table 3.
In our study, IVT before intervention is associated with
recanalization success. In the successful group (SG), 51.5%
of all patients were treated with intravenous tissue
plasminogen activator, while in the failure group (FG), only
35.0% received this medication (p = 0.032). Furthermore,
there was a statistical correlation between the long-term intake
of nitrates and a successful intervention (SG = 8.0% vs. FG =
1.0%; p = 0.035).
Intervention duration was significant longer in failing interven-
tions (SG=23 (14–36) min vs. FG=50 (36–90) min; p= 0.000).
Regarding coagulation therapy with coumarins or direct
oral anticoagulants, no significant difference was found in
any of the groups. Time factors related to symptom onset, to
IVT, and to intervention do not seem to play a role in the
success of recanalization. Laboratory parameters for inflam-
matory response and coagulation were comparable in all
groups (see Table 2).
Subgroup analysis
In addition to the results given for the total failing group, there
are interesting findings for the two subgroups:
6.2; 1
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2.1 9 9.0% 45.0%
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2.3 -pre-exisng dissecon 1 1.0% 5.0%
3 passage not possible 2 2.0% 10.0%
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Female (%) 60 (60.0) 47 (47.0) 0.089A 9 (45.0) 0.227A 38 (47.5) 0.100A
Male (%) 40 (40.0) 53 (53.0) 0.089A 11 (55.0) 0.227A 42 (52.5) 0.100A
Age [years]
(X̅ ± SD)
73.4 ± 12.8 71.1 ± 12.9 0.132B 74.9 ± 10.8 0.972B 70.1 ± 13.3 0.078B
A, Fisher’s exact test; B, Mann-Whitney U test; X̅, mean; SD, standard deviation
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Table 3 Patient-related parameters (p values are given for a comparison of the group of failing interventions with the successful group and for a










Nicotine abuse (%) 22 (22.0) 24 (24.0) 0.876A 6 (30.0) 0.562A 18 (22.5) 1.000A
Coronary heart disease/myocardial infarction (%) 25 (25.0) 22 (22.0) 0.739A 7 (35.0) 0.409A 15 (18.8) 0.369A
Atrial fibrillation (%) 52 (52.0) 39 (39.0) 0.088A 10 (50.0) 1.000A 29 (36.3) 0.037A
Diabetes mellitus (%) 18 (18.0) 17 (17.0) 1.000A 4 (20.0) 0.761A 13 (16.2) 1.000A
Heart failure (%) 8 (8.0) 14 (14.0) 0.258A 2 (10.0) 0.672A 12 (15.0) 0.157A
Hyperlipoproteinemia (%) 27 (27.0) 27 (27.0) 1.000A 6 (30.0) 0.788A 21 (26.2) 1.000A
Hypertension (%) 74 (74.0) 72 (72.0) 0.874A 16 (80.0) 0.778A 56 (70.0) 0.616A
Chronic kidney disease (%) 8 (8.0) 8 (8.0) 1.000A 2 (10.0) 0.672A 7 (8.8) 1.000A
Patent foramen ovale (%) 2 (2.0) 5 (5.0) 0.445A 0 (0.0) 1.000A 5 (6.3) 0.244A
Endocarditis (%) 1 (1.0) 0 (0.0) 1.000A 0 (0.0) 1.000A 0 (0.0) 1.000A
Peripheral arterial occlusive disease (%) 4 (4.0) 10 (10.0) 0.164A 4 (20.0) 0.026A 6 (7.5) 0.343A
Autoimmune disease# (%) 2 (2.0) 4 (4.0) 0.683A 0 (0.0) 1.000A 4 (5.0) 0.409A
Tumors+ (%) 6 (6.0) 7 (7.0) 1.000A 1 (5.0) 1.000A 6 (7.5) 0.768A
Coagulation disorder~ (%) 1 (1.0) 6 (6.0) 0.118A 0 (0.0) 1.000A 6 (7.5) 0.046A
Stroke/TIA in history (%) 19 (19.0) 16 (16.0) 0.710A 5 (25.0) 0.547A 11 (13.8) 0.423A
Thrombosis/lung embolism in history (%) 2 (2.0) 4 (4.0) 0.683A 1 (5.0) 0.424A 3 (3.8) 0.479A
Low molecular weight heparin (%) 6 (6.0) 3 (3.0) 0.498A 2 (10.0) 0.619A 1 (1.3) 0.134A
Unfractionated heparin (%) 3 (3.0) 1 (1.0) 0.621A 0 (0.0) 1.000A 1 (1.3) 0.630A
Coumarins (%) 10 (10.0) 9 (9.0) 1.000A 1 (5.0) 0.689A 8 (10.0) 1.000A








































Ace-inhibitors (%) 30 (30.0) 27 (27.0) 0.754A 8 (40.0) 0.435A 19 (23.8) 0.401A
AT1-receptor antagonists 8%) 23 (23.0) 19 (19.0) 0.603A 4 (20.0) 1.000A 15 (18.8) 0.582A
Betablockers (%) 61 (61.0) 55 (55.0) 0.474A 12 (60.0) 1.000A 43 (53.8) 0.364A
Diuretics (%) 35 (35.0) 43 (43.0) 0.310A 9 (45.0) 0.450A 34 (42.5) 0.355A
Calcium channel blockers (%) 27 (27.0) 19 (19.0) 0.239A 3 (15.0) 0.397A 16 (20.0) 0.296A
Nitrates (%) 8 (8.0) 1 (1.0) 0.035A 1 (5.0) 1.000A 0 (0.0) 0.009A
Statins (%) 31 (31.0) 30 (30.0) 1.000A 10 (50.0) 0.124A 20 (25.0) 0.409A
Metamizole (%) 10 (10.0) 9 (9.0) 1.000A 2 (10.0) 1.000A 7 (8.8) 0.804A
Ibuprofen (%) 2 (2.0) 4 (4.0) 0.682A 0 (0.0) 1.000A 4 (5.0) 0.409A
Acetylsalicylic acid (%) 21 (21.0) 31 (31.0) 0.146A 9 (45.0) 0.044A 22 (27.5) 0.380A
Clopidogrel (%) 4 (4.0) 8 (8.0) 0.373A 3 (15.0) 0.090A 5 (6.3) 0.514A
Thyroxine (%) 17 (17.0) 16 (16.0) 1.000A 4 (20.0) 0.751A 12 (15.0) 0.839A
Glucocorticoids (%) 2 (2.0) 5 (5.0) 0.445A 2 (10.0) 0.129A 3 (3.8) 0.657A
Lesion in internal carotid artery (%) 40 (40.0) 42 (42.0) 0.886A 13 (65.0) 0.050A 29 (36.3) 0.646A
Lesion in middle cerebral artery. M1 (%) 49 (49.0) 39 (39.0) 0.200A 3 (15.0) 0.006A 36 (45.0) 0.653A
Lesion in middle cerebral artery M2 (%) 11 (11.0) 19 (19.0) 0.165A 4 (20.0) 0.274A 15 (18.8) 0.200A
Right hemisphere (%) 43 (43.0) 39 (39.0) 0.666A 11 (55.0) 0.338A 28 (35.0) 0.287A
Left hemisphere (%) 57 (57.0) 61 (61.0) 0.666A 9 (45.0) 0.338A 52 (65.0) 0.287A
Initial NIH-Stroke-Scale (M and IQR) 15 (11–19) 14 (10–19) 0.578B 14 (10–17) 0.457A 15 (10–20) 0.723B
Intravenous thrombolysis (%) 51 (51.0) 35 (35.0) 0.032A 7 (35.0) 0.226A 28 (35.0) 0.035A
Thrombolysis-intervention time [min] (M and
IQR)
90 (41–151) 118 (47–161) 0.351B 139 (79–228) 0.142A 102 (46–152) 0.652B
Onset-needle time [min] (M and IQR) 90 (73–126) 91 (77–117) 0.413B 95 (80–150) 0.793B 91 (75–132) 0.404B
Onset-groin-puncture time [min] (M and IQR) 158 (125–198) 189 (134–261) 0.608B 271 (151–333) 0.155B 200 (140–270) 0.973B
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Compared to the successful group, in group A (A) there is a
strong association between failing intervention and PAOD
(SG = 4.0% vs. A = 20.0%; p = 0.026) as well as the intake
of acetylsalicylic acid (SG = 21.0% vs. A = 45.0%; p =
0.044). In group A, lesions are significantly more often locat-
ed in the internal carotid artery (SG = 40.0% vs. A = 65.0%;
p = 0.050) and more rarely in the middle cerebral artery, seg-
ment M1 (SG = 49.0% vs. A = 15.0%; p = 0.006).
In group B (B), atrial fibrillation (AF) is associated with
recanalization success (SG = 52.0% vs. B = 36.3%; p =
0.037), whereas coagulation disorders are associated with
poor results (SG = 1.0% vs. B = 7.5%; p = 0.046).
Coagulation disorders particularly were defined as heterozy-
gous (1 patient in B) and homozygous G20210A mutation (0
patients), antiphospholipid syndrome (2 patients, 1 in SG and
1 in B), factor V Leiden mutation (2 patients in B), protein c/s
deficiency (1 patient in B), thrombotic thrombocytopenic pur-
pura (0 patients), or paraneoplastic coagulation disorder (1
patient in B).
Discussion
Several retrospective investigations concerning failing
thrombectomy were published in recent months [13, 14]. In
our study, we were able to detect success rates of 83.2% at our
center. We analyzed interventions from 2014 to 2018. In this
period, major improvements of material and methods were
made [15]. We found a peak of failing interventions in the
year 2015 with many recanalization results of mTICI 2a.
When having a second look at the angiographic reports, no
reason therefore could be found, especially no discrepancies
in material or interventionalist. In 2014 and from 2016 to
2018, the success rate at our center is in the range of 83–
86%. Recent literature comes to similar success rates of
around 80–89% [6, 16], while older reviews indicate success
rates of 80% [17].
A major problem when comparing different studies is the
heterogeneous definition of success. In particular, a reperfu-
sion result of mTICI 2a is sometimes regarded as success,
sometimes as failure [6, 13, 14, 18, 19].
In 20% of the failing interventions, the thrombus could not
be reached or passed with the device while in 80% recanali-
zation failed due to other reasons. Literature reports similar
data [13]. For patients failing due to mechanical reasons, di-
rect carotid puncture or surgical vascular access, which is
currently not performed at our center, could be a therapeutic
option in certain cases. Direct carotid puncture is a high-risk
procedure, but recent literature reports successful recanaliza-
tion in 8/11 reported cases, where a femoral approach had
failed [20]. Further options for access problems, e.g., neck
extension to stretch tortuous or elongated vessels should be
investigated in upcoming studies [21].
In addition to procedural aspects, we analyzed patients’
medical history. IVT is associated with improved recanaliza-
tion rates. This can be explained by the pharmacologic mech-
anism: the clot is dissolved from the outer edge and can there-
fore be accessed by the mechanical device easier [22].
Another explanation could be, that small fragments of the
initial thrombus are dissolved during the intervention and do
not occlude distal branches. Several other studies come to











Onset-end-of-intervention Time [min] (M and
IQR)
194 (145–239) 236 (220–301) 0.055B 308 (188–375) 0.199B 272 (202–318) 0.085B
Intervention duration [min] (M and IQR) 23 (14–36) 50 (36–90) 0.000B 27.5 (23–52) 0.665B 58 (44–73) 0.000B
Stroke of unknown onset (%) 20 (20) 26 (26) 0.401A 6 (30.0) 0.374A 20 (25.0) 0.473A
C-reactive protein [mg/l] (M and IQR) 4.5 (1.9–14.6) 5.3 (2.4–15.4) 0.342B 6.1 (1.7–24.1) 0.420B 5.1 (2.5–12.1) 0.431B
White blood cell count [×109/l] (X̅ ± SD) 10.6 ± 4.2 10.4 ± 5.3 0.284B 10.1 ± 4.3 0.576B 9.2 ± 3.9 0.303B









aPTT [s] (M and IQR) 24 (23–27) 24 (22–27) 0.639B 25 (22–28) 0.899B 24 (23–27) 0.546B
Platelet count [×109/l] (M and IQR) 228 (186–274) 223 (160–277) 0.258B 199 (142–276) 0.108B 227 (170–277) 0.500B
A, Fisher’s exact test; B, Mann-Whitney U test; M, median, IQR, interquartile range; X̅, mean; SD, standard deviation
#Vasculitis, Hashimoto thyroiditis, Crohn’s disease, rheumatoid arthritis, myasthenia gravis. No significant difference in any of the subcategories
+Active tumor disease: small cell lung cancer, non-small cell lung cancer, colorectal carcinoma, mammary carcinoma, non-Hodgkin’s lymphoma,
chronic lymphocytic leukemia, plasmocytoma, malignant melanoma, thyroid cancer, transitional cell carcinoma of the urinary tract, oropharyngeal
squamous cell carcinoma, meningeoma, prostate cancer, cancer of unknown primary. No significant difference in any of the subcategories
~Heterozygous and homozygous G20210A-mutation, antiphospholipid syndrome, factor V Leiden mutation, protein c/s-deficiency, thrombotic throm-
bocytopenic purpura, paraneoplastic coagulation disorder. No significant difference in any of the subcategories
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IVT for recanalization success, as shown in a recent review by
Pan et al. [23]. It was to be expected that vascular diseases
such as PAOD influence MT in a negative way. Coagulation
disorders also are a challenge for interventional treatment,
especially because of a high rate of re-occlusion during the
intervention. We were able to prove a significant correlation
between PAOD and failing intervention, as well as between
coagulation disorders and unsuccessful thrombectomy.
In the group of patients where thrombus could be reached
but the vessel remained occluded, AF is significantly less
frequent. Recent literature also shows inconclusive findings
concerning this aspect [24]. There are studies and histological
analysis that come to a similar result [25, 26], while other
investigations indicate the opposite: cardiogenic thrombi seem
to have a higher proportion of fibrin compared to other stroke
etiologies, associated with worse interventional recanalization
rates [27–29]. More studies on thrombus etiology and throm-
bus composition must be performed.
It is not clear why there is a strong association of intake of
NO donors and reperfusion success. Recent studies investigat-
ed NO donors as symptomatic treatment for acute ischemic
stroke, but not as a medication to improve recanalization suc-
cess [30]. Further studies are required to find out whether the
result is an artifact or not.
There was no difference in any kind of anticoagulation
therapy with coumarins, NOAC, or heparins regarding recan-
alization success. This is of special interest since many future
patients will take NOACs instead of coumarins and we do not
know the effects of NOACs on thrombus characteristics.
In the subgroup of failing interventions, where target lesion
could be reached with the device, techniques should be im-
proved, and new material should be developed. For example,
recent studies suggest a proximal balloon occlusion during stent
retriever withdrawal to protect the distal vessel from thrombus
fragments that have sheared off [31]. As a rescue therapy, per-
manent stenting or intraarterial thrombolysis as well as adminis-
tration of tirofiban are options worth considering [32–34]. In
certain cases, creativity on the part of the interventionalist can
lead to success: there are case reports of dual-use of stent re-
trievers for refractory clots involving vessels’ bifurcation [35].
In general, more evidence for the question of how to treat patients
with failing thrombectomy is required.
Since all patients in both groups were under general anes-
thesia during the intervention and we investigated the recana-
lization itself, we did not analyze anesthesiologic medication
or blood pressure during the intervention. In literature, there is
evidence for anesthesiologic management influencing out-
come, but not recanalization results [36–39].
Limitation
It should be noted that only angiographic data and no clinical
parameters concerning patient outcome were collected.
Nevertheless, there is a strong correlation between successful re-
perfusion and patients’ outcome, as shown in recent literature [9,
10, 19, 40]. The study cohort is the same size as in other compa-
rable studies. Another limitation is the retrospective study design.
Conclusion
There are two main reasons for failing MT:
Major problems of failing thrombectomy, on the one hand,
include a difficult vascular situation affecting interventional
treatment in 20% of all failing interventions. The target lesion
cannot be reached and/or passed with the device. Especially in
those patients, PAOD is a common previous disease.
In the other 80% of all failing interventions, thrombus can
be passed with the device, but the occluded vessel cannot be
recanalized. Coagulation disorders are associated with poor
results, whereas atrial fibrillation, intake of NO donators,
and administration of intravenous thrombolysis are associated
with higher recanalization rates.
Future research on improving recanalization rates should
concentrate on the two key areas of access problems and true
stent retriever failure.
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